Two Sigma Investments’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-461,415
| Closed | -$39.2M | – | 3943 |
|
|
2020
Q3 | $39.2M | Sell |
461,415
-533,179
| -54% | -$27M | 0.14% | 150 |
|
|
2020
Q2 | $35.2M | Buy |
994,594
+976,294
| +5,335% | +$28.5M | 0.17% | 120 |
|
|
2020
Q1 | $247K | Sell |
18,300
-74,626
| -80% | -$1.26M | ﹤0.01% | 2485 |
|
|
2019
Q4 | $1.97M | Buy |
+92,926
| New | +$1.64M | 0.01% | 1604 |
|
|
2018
Q4 | – | Sell |
-12,100
| Closed | -$252K | – | 3721 |
|
|
2018
Q3 | $252K | Sell |
12,100
-3,248
| -21% | -$76.9K | ﹤0.01% | 2877 |
|
|
2018
Q2 | $363K | Buy |
+15,348
| New | +$308K | ﹤0.01% | 2827 |
|
|
2017
Q4 | – | Sell |
-662,014
| Closed | -$9.26M | – | 3578 |
|
|
2017
Q3 | $9.26M | Buy |
662,014
+172,127
| +35% | +$1.72M | 0.03% | 551 |
|
|
2017
Q2 | $4.33M | Buy |
489,887
+288,787
| +144% | +$2.03M | 0.02% | 939 |
|
|
2017
Q1 | $1.3M | Buy |
201,100
+138,800
| +223% | +$703K | ﹤0.01% | 1744 |
|
|
2016
Q4 | $229K | Buy |
+62,300
| New | +$184K | ﹤0.01% | 2875 |
|
|
2015
Q1 | – | Sell |
-40,975
| Closed | -$197K | – | 2952 |
|
|
2014
Q4 | $197K | Buy |
+40,975
| New | +$162K | ﹤0.01% | 2051 |
|
Two Sigma Investments's IMMU Position: Q4 2020 in Review
Two Sigma Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 461,415 shares — an estimated $39.2M sold.
Two Sigma Investments first reported a position in IMMU in Q4 2014 and held it in 11 quarters. The position peaked at $39.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Two Sigma Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Two Sigma Investments sold 461,415 Immunomedics Inc shares in Q4 2020, an estimated $39.2M.
- Two Sigma Investments first reported a position in Immunomedics Inc in Q4 2014 and held it in 11 quarters.
- Two Sigma Investments's Immunomedics Inc position peaked at $39.2M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.